ReShape Lifesciences Inc. (NASDAQ: RSLS) Stock Information | RedChip

ReShape Lifesciences Inc. (NASDAQ: RSLS) Listen to this Section


$0.18
+0.0011 ( +0.63% ) 506.2K

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Market Data


Open


$0.18

Previous close


$0.18

Volume


506.2K

Market cap


$4.21M

Day range


$0.18 - $0.19

52 week range


$0.14 - $1.29

Insider Ownership Transactions

Total Amount Purchased: -147.00 | $ -26.05

Date Type Amount Purchased Purchaser
2024-08-13 Sale -39.00 STANKOVICH THOMAS
2023-11-08 Sale -108.00 STANKOVICH THOMAS

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 62 Aug 14, 2024
8-k 8K-related 16 Aug 14, 2024
4 Insider transactions 1 Aug 13, 2024
8-k 8K-related 21 Jul 09, 2024
8-k 8K-related 16 May 20, 2024
10-q Quarterly Reports 60 May 15, 2024
8-k 8K-related 15 Apr 10, 2024
8-k 8K-related 13 Apr 10, 2024
8-k 8K-related 15 Apr 04, 2024
10-k Annual reports 88 Apr 01, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.